A new global study warns that chronic kidney disease is quietly becoming a major public health crisis, with cases worldwide ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect and slow the condition early.

(THE CONVERSATION) The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the ...

LSU’s Pennington Biomedical Research Center announced that Dr. Corby Martin has been appointed as the Associate Executive ...

Multiple factors contribute to rising obesity rates. However, excess caloric intake remains the primary driver. This conclusion is supported by multiple lines of evidence, including observational ...

Teen obesity in the Yakima Valley has become a serious issue. It’s a growing problem, and it’s time to act. We need to ...

The Trump administration is proposing to weigh immigrants' use of programs like Medicaid or SNAP, as well as other public ...

That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

Two obesity medicine societies and an advocacy group have teamed up to produce US-specific evidence-based guidance on obesity ...

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...